A hydroxypyridinone (CP94) enhances protoporphyrin IX formation in 5-aminolaevulinic acid treated cells

J Photochem Photobiol B. 1997 Nov;41(1-2):136-44. doi: 10.1016/s1011-1344(97)00095-x.

Abstract

Different cell lines were given photodynamic treatment with 5-aminolaevulinic acid (ALA) and light. In addition, the iron chelator 1,2-diethyl-3-hydroxypyridin-4-one (CP94) was used. The porphyrin species produced was spectrofluorimetrically identified as protoporphyrin IX. All the cell lines responded to treatment, including a multidrug resistance gene expressing bladder cancer line and, to a lesser degree, cells derived from untransformed human skin fibroblasts. CP94 enhanced both porphyrin fluorescence, total porphyrin content and photosensitivity of the cells. CCD fluorescence microscopy showed a granular extranuclear porphyrin fluorescence distribution for all the cell lines involved, but the untransformed cells showed a distribution pattern different from the ones seen in the other cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aminolevulinic Acid / pharmacology*
  • Aminolevulinic Acid / toxicity
  • Cell Line
  • Darkness
  • Humans
  • Iron Chelating Agents / chemistry
  • Iron Chelating Agents / pharmacology*
  • Iron Chelating Agents / toxicity
  • Microscopy, Fluorescence
  • Molecular Structure
  • Prodrugs / pharmacology*
  • Prodrugs / toxicity
  • Protoporphyrins / biosynthesis*
  • Pyridones / chemistry
  • Pyridones / pharmacology*
  • Pyridones / toxicity
  • Spectrometry, Fluorescence

Substances

  • Iron Chelating Agents
  • Prodrugs
  • Protoporphyrins
  • Pyridones
  • 1,2-diethyl-3-hydroxypyridin-4-one
  • Aminolevulinic Acid
  • protoporphyrin IX